Literature DB >> 15140757

Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered.

Debby P Y Koonen1, Carley R Benton, Yoga Arumugam, Narendra N Tandon, Jorge Calles-Escandon, Jan F C Glatz, Joost J F P Luiken, Arend Bonen.   

Abstract

We examined whether skeletal muscle transport rates of long-chain fatty acids (LCFAs) were altered when muscle activity was eliminated (denervation) or increased (chronic stimulation). After 7 days of chronically stimulating the hindlimb muscles of female Sprague-Dawley rats, the LCFA transporter proteins fatty acid translocase (FAT)/CD36 (+43%) and plasma membrane-associated fatty acid-binding protein (FABPpm; +30%) were increased (P < 0.05), which resulted in the increased plasmalemmal content of these proteins (FAT/CD36, +42%; FABPpm +13%, P < 0.05) and a concomitant increase in the LCFA transport rate into giant sarcolemmal vesicles (+44%, P < 0.05). Although the total muscle contents of FAT/CD36 and FABPpm were not altered (P > 0.05) after 7 days of denervation, the LCFA transport rate was markedly decreased (-39%). This was associated with reductions in plasmalemmal FAT/CD36 (-24%) and FABPpm (-28%; P < 0.05). These data suggest that these LCFA transporters were resequestered to their intracellular depot(s) within the muscle. Combining the results from these experiments indicated that changes in rates of LCFA transport were correlated with concomitant changes in plasmalemmal FAT/CD36 and FABPpm, but not necessarily with their total muscle content. Thus chronic alterations in muscle activity can alter the rates of LCFA transport via different mechanisms, either 1) by increasing the total muscle content of FAT/CD36 and FABPpm, resulting in a concomitant increase at the sarcolemma, or 2) by reducing the plasma membrane content of these proteins in the absence of any changes in their total muscle content.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140757     DOI: 10.1152/ajpendo.00531.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  23 in total

Review 1.  Role of intramyocelluar lipids in human health.

Authors:  Paul M Coen; Bret H Goodpaster
Journal:  Trends Endocrinol Metab       Date:  2012-06-20       Impact factor: 12.015

2.  Regulation of fatty acid transport: from transcriptional to posttranscriptional effects.

Authors:  Adrian Chabowski; Jan Górski; Arend Bonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07       Impact factor: 3.000

3.  Tissue-specific and fatty acid transporter-specific changes in heart and soleus muscle over a 1-yr period.

Authors:  Arend Bonen; James G Nickerson; Iman Momken; Adrian Chabowski; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.

Authors:  Adrian Chabowski; Iman Momken; Susan L M Coort; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Mol Cell Biochem       Date:  2006-05-19       Impact factor: 3.396

Review 5.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

6.  In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation.

Authors:  Graham P Holloway; Laelie A Snook; Robert J Harris; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

7.  Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.

Authors:  Graham P Holloway; Jamie Lally; James G Nickerson; Hakam Alkhateeb; Laelie A Snook; George J F Heigenhauser; Jorge Calles-Escandon; Jan F C Glatz; Joost J F P Luiken; Lawrence L Spriet; Arend Bonen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

8.  Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.

Authors:  Jacob Jeppesen; Peter Albers; Joost J Luiken; Jan F C Glatz; Bente Kiens
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

9.  Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.

Authors:  James G Nickerson; Hakam Alkhateeb; Carley R Benton; James Lally; Jennifer Nickerson; Xiao-Xia Han; Meredith H Wilson; Swati S Jain; Laelie A Snook; Jan F C Glatz; Adrian Chabowski; Joost J F P Luiken; Arend Bonen
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

10.  Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.

Authors:  Carley R Benton; Debby P Y Koonen; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; John J Heikkila; Arend Bonen
Journal:  J Physiol       Date:  2006-02-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.